trial

Cannabinoids, Learning, and Memory

NCTId NCT02407808
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 1 · Active Not Recruiting
Enrollment 80 (estimated)
Sponsored by Yale University
Primary completion 2018-08-10
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 1
Status
Active Not Recruiting
Enrollment
80 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Quadruple
Start
2015-02
Primary completion
2018-08-10
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
THC

Sponsors

Yale UniversityLead Sponsor

Investigators

1
Mohini Ranganathan, M.D.Principal Investigator

Sites

1 total
West Haven, United States

Facts & assertions

4 sourced
Enrollment
80
Phase
PHASE1
Primary Completion Date
2018-08-10
Status
ACTIVE_NOT_RECRUITING
relationships
The graph out of here
drug
THC
drug
lead_sponsor
Yale University
company
indication
Psychotic Disorders
indication
Psychotic Disorders
indication
Cannabis
indication
investigator
Mohini Ranganathan, M.D.
person